These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23400499)

  • 1. Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy.
    Kent L; Davies P; Kennett R; Wimalaratna S; Kerr R; Turner MR; Talbot K
    J Neurol; 2013 Apr; 260(4):1166-7. PubMed ID: 23400499
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of masseter spasticity by botulinum toxin facilitates PEG placement in amyotrophic lateral sclerosis.
    Restivo DA; Lanza S; Marchese-Ragona R; Palmeri A
    Gastroenterology; 2002 Nov; 123(5):1749-50. PubMed ID: 12404262
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study.
    Vázquez-Costa JF; Máñez I; Alabajos A; Guevara Salazar M; Roda C; Sevilla T
    J Neurol; 2016 Oct; 263(10):1954-60. PubMed ID: 27383643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
    Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
    Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review.
    Oliveira AF; Silva GA; Almeida DM
    Einstein (Sao Paulo); 2016; 14(3):431-434. PubMed ID: 27759834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis.
    Anagnostou E; Rentzos M; Alexakis T; Zouvelou V; Zambelis T; Evdokimidis I
    Muscle Nerve; 2013 Feb; 47(2):276-8. PubMed ID: 23281147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands.
    Bushara KO
    Med Hypotheses; 1997 Apr; 48(4):337-9. PubMed ID: 9160288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis.
    Singer C; Papapetropaulos S; Ayyar DR; Verma A
    Mov Disord; 2007 Jan; 22(2):289. PubMed ID: 17094101
    [No Abstract]   [Full Text] [Related]  

  • 9. Teaching Video NeuroImage: Disabling Jaw Clonus in a Patient With Bulbar-Onset Amyotrophic Lateral Sclerosis Successfully Treated With Botulinum Toxin.
    Oliveira Santos M; Schön M; Valadas A; de Carvalho M
    Neurology; 2022 Oct; 99(15):671. PubMed ID: 36216527
    [No Abstract]   [Full Text] [Related]  

  • 10. ALS dysphagia pathophysiology: differential botulinum toxin response.
    Restivo DA; Casabona A; Nicotra A; Zappia M; Elia M; Romano MC; Alfonsi E; Marchese-Ragona R
    Neurology; 2013 Feb; 80(7):616-20. PubMed ID: 23345638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum Toxin Type A Injections as an Effective Treatment of Refractory Multiple Sclerosis-Related Trigeminal Pain - A Case Report.
    Calejo M; Salgado P; Moreira B; Correia C; Barros J
    Headache; 2019 Sep; 59(8):1379-1381. PubMed ID: 31424566
    [No Abstract]   [Full Text] [Related]  

  • 12. Injection of botulinum toxin for treatment of chronic lateral epicondylitis.
    Lin YC; Chen SM; Kuan TS; Hsieh PC; Guo YH; Lin IL; Jou IM
    Semin Arthritis Rheum; 2012 Jun; 41(6):e1-2. PubMed ID: 22341513
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.
    Costa J; Rocha ML; Ferreira J; Evangelista T; Coelho M; de Carvalho M
    J Neurol; 2008 Apr; 255(4):545-50. PubMed ID: 18283399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study.
    Gilio F; Iacovelli E; Frasca V; Gabriele M; Giacomelli E; Picchiori F; Soldo P; Cipriani AM; Ruoppolo G; Inghilleri M
    Amyotroph Lateral Scler; 2010 Aug; 11(4):359-63. PubMed ID: 19929745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
    Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ
    Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is lateral epicondylitis a new indication for botulinum toxin?
    Buchbinder R; Richards BL
    CMAJ; 2010 May; 182(8):749-50. PubMed ID: 20421352
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
    Habek M; Adamec I; Gabelić T; Brinar VV
    Acta Neurol Belg; 2012 Dec; 112(4):423-4. PubMed ID: 22669610
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
    Wynn RL
    Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
    [No Abstract]   [Full Text] [Related]  

  • 19. Acquired lateral upper lid entropion in a child treated with Botulinum toxin.
    Ashena Z; Webber S
    Eye (Lond); 2012 Oct; 26(10):1390-1. PubMed ID: 22878440
    [No Abstract]   [Full Text] [Related]  

  • 20. Noncosmetic uses of botulinum toxin.
    Zalvan C; Bentsianov B; Gonzalez-Yanes O; Blitzer A
    Dermatol Clin; 2004 Apr; 22(2):187-95. PubMed ID: 15222579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.